CHINA SXT PHARMACEUTICALS IN (SXTC) Stock Earnings & Estimates
USA - NASDAQ:SXTC - VGG2161P1577 - Common Stock
1.32 USD
+0.02 (+1.54%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.97M -24.23% | 1.929M -2.11% | 1.741M -9.73% | |
| EBITDA YoY % growth | -5.01M -2.87% | -1.889M 62.29% | -1.592M 15.72% | |
| EBIT YoY % growth | -5.26M -1.35% | -2.092M 60.22% | -1.674M 19.97% | |
| Operating Margin | -267.01% | -108.49% | -96.18% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 911.4K -7.84% | % | ||
| Q2 2025 Q2Q % growth | 829.5K -11.72% | % | ||
| Q4 2024 Q2Q % growth | 988.9K 30.12% | % | ||
| Q2 2024 Q2Q % growth | 939.6K -22.35% | % | ||
| Q4 2023 Q2Q % growth | 760K -51.59% | % | ||
| Q2 2023 Q2Q % growth | 1.21M 17.48% | % | ||
| Q4 2022 Q2Q % growth | 1.57M 70.65% | % | ||
| Q2 2022 Q2Q % growth | 1.03M -73.32% | % | ||
| Q4 2021 Q2Q % growth | 920K -52.82% | % | ||
| Q2 2021 Q2Q % growth | 3.86M 19.88% | % | ||
| Q4 2020 Q2Q % growth | 1.95M -36.89% | % | ||
| Q2 2020 Q2Q % growth | 3.22M -17.86% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |